Some providers featured on this site may compensate us. This may affect the order and placement of listings but does not influence our editorial ratings or reviews.
Treatments Hub

Verified prices

All verified prices
Comparison6 min read

DirectMeds Alternatives 2026: By Medication, Not by List

The right DirectMeds alternative differs by GLP-1 medication: semaglutide users have five cheaper options, tirzepatide users a published price, drops users none.

Updated September 15, 2026

Medically reviewed on

How we review

Key takeaways

  • The right alternative depends on your medication: semaglutide patients have five cheaper options, tirzepatide patients a published price, and drops patients none.
  • Semaglutide: welludr $41 (12-month lock), embody $49 flat with no commitment, altRx $89 with BNPL and a brand-name shelf, Medvi $99 promo, HealthRx $125 after a $39 first month - annual savings of $1,488-$2,496 against $249, none with a needle-free format.
  • Tirzepatide: DirectMeds publishes no price, so there is nothing to beat - welludr is $71 (12-month plan), embody $99 flat, altRx $149, Medvi $166 promo, HealthRx $199, TrimRx $259, SHED $299.
  • Do not spend weeks optimizing a $30-$80/month gap while not starting treatment - pick the provider that fits your constraint, start, and revisit in month three with real data.

Three customers, three different answers

The short answerThe right DirectMeds alternative depends on your medication. Semaglutide patients have five cheaper options: welludr $41 on a 12-month lock, embody $49 flat with no commitment, altRx $89 with BNPL and a brand-name shelf, Medvi $99 promotional, and HealthRx $125 after a $39 first month, saving $1,488 to $2,496 a year against $249. Tirzepatide patients have a published price at welludr $71 and embody $99, among others; DirectMeds publishes none. Drops patients have none, because no other ranked provider offers a needle-free format.

Generic alternatives lists fail DirectMeds shoppers because the $249 means different things to different patients. So we'll answer three people separately: the semaglutide patient (five cheaper options), the tirzepatide patient (no DirectMeds price to compare), and the drops patient (no alternatives exist - but staying has conditions worth knowing).

Our top-rated GLP-1 providers

Our recommended telehealth providers - the same cards from our full comparison.

Our Top Pick
1
embody logo

Exceptional

9.8out of 10

Compounded GLP-1 from $49/month; not FDA-approved, free expedited delivery

Free expedited deliveryNo hidden fees
  • Compounded semaglutide ($49/mo) and tirzepatide ($99/mo) as shown on the homepage, Nov 16, 2026; not FDA-approved
  • Online intake, then a prescriber review by OpenLoop Health, a network of US-licensed doctors
  • Free expedited delivery (embody's words); the Terms do not guarantee a delivery timeline
  • No insurance required, no clinic visits; cancel at least 72 hours before the next billing date

from $49/month

Doctor-prescribed compounded GLP-1 treatment, not FDA-approved: semaglutide shown at $49/month and tirzepatide at $99/month on embody's homepage (Nov 16, 2026), no insurance required.

Read full embody review
2
altRx logo

Excellent

9.4out of 10

Most Comprehensive GLP-1 Medication Access

Transparent pricingNo insurance required
  • Compounded GLP-1 from $89/mo, GLP-1 + GIP from $149/mo
  • Brand-name options too: Zepbound and Wegovy
  • Clinician-guided - physician, PA, or nurse practitioner
  • Free shipping (about 5-7 days)

from $89/month

Affordable GLP-1 program from $89/month - compounded semaglutide and tirzepatide plus brand-name options - with clinician-guided, self-pay care and no insurance required.

Read full altRx review
3
TrimRx logo

Very Good

8.9out of 10

Limited time offer - $140 off all weight loss plans

HIPAA compliantMade in USA
  • Compounded semaglutide $149/month - same price at every dose
  • Compounded tirzepatide $259/month
  • Custom dosing with unlimited provider check-ins
  • Free consultation and free tracked delivery - often next-day

from $149/month

Telehealth GLP-1 program built around custom dosing and unlimited provider check-ins - compounded semaglutide $149/month, the same at every dose, and tirzepatide $259/month.

Read full TrimRx review

Semaglutide patient? Five ways to pay less

At $249 you're above five rivals for the identical active ingredient: welludr at $41 (12-month lock, coach and warranty included), embody at $49 flat (no commitment, free expedited delivery, partial refund if not approved - the closest match to DirectMeds' no-nonsense spirit), altRx at $89 (flat at every dose, BNPL, brand-name shelf), Medvi at $99 promotional with video visits and a dietician, and HealthRx at $125 after a $39 first month with overnight cold-chain shipping. Annual savings range $1,488-$2,496. The trade at each: none offers a needle-free format.

Tirzepatide patient? Start with the published prices

DirectMeds publishes no tirzepatide price, so start with those that do. welludr does tirzepatide at $71, with the best rate tied to a 12-month plan. embody charges $99 flat with no commitment and faster default shipping cadence. Others charge more: altRx $149, Medvi $166 promo, HealthRx $199, TrimRx $259, SHED $299. Unless one of those brings something you specifically need (Medvi's support, SHED's guarantee), your shortlist is two names long.

Shop GLP-1 plans by product

The lowest published plans - cheapest first, conditions under each price.

The mistake worse than the wrong provider

A pattern we see in provider-shopping deserves naming: spending weeks optimizing a $30-$80/month difference while not starting treatment at all. The clinical literature is unambiguous that results compound with time on effective doses - every month of comparison shopping is a month of results not accruing. The financial version of the same point: the gap between DirectMeds and the cheapest alternative ($208/month at most) is real money, so price-check, but do it inside a week. Pick the provider whose model fits your actual constraint - needles, cash flow, medication - inside a week, start, and revisit the choice in month three with real data about how your body responds. Providers are switchable; time isn't.

What To Know Before Starting GLP-1 Treatment

Before starting GLP-1 treatment, it's important to understand a few key things. These medications require a prescription from a licensed clinician and aren't suitable for everyone. Some people may experience side effects, especially during the first few weeks as the body adjusts.

GLP-1s also tend to work best when combined with basic lifestyle habits like balanced nutrition and regular physical activity.

That's why choosing a provider that offers proper medical screening and ongoing follow-up support is essential for both safety and long-term success.

Woman preparing GLP-1 weight loss injection

Drops patient? Stay - but hold it to a standard

No provider in our ranking offers another needle-free GLP-1 format, so switching means switching to injections. If drops are working for you under your prescribing doctor's monitoring, the practical move is staying while holding the arrangement to the standard any GLP-1 treatment deserves: measurable progress reviewed with your clinician (the yardstick: what a reasonable first month looks like). If results lag, the conversation isn't "which provider" - it's "which format," and the injectable tier reopens with every option above.

You take...Best alternativePriceThe string attached
Semaglutidewelludr$41/mo12-month lock for best rate
Semaglutide, no commitmentembody$49/moInjections only
Tirzepatidewelludr$71/moSame lock
Tirzepatide, flexibleembody$99/moInjections only
Sublingual drops- (unique)$249/moReview progress with your doctor

→ Or let the quiz run this logic for you: find your match

This article is general information, not medical advice. Prices as listed at the time of writing.

Ready to compare weight loss providers?

See how top providers stack up on pricing, medical support, and treatment options.

Medical disclaimer

This page is general information about GLP-1 weight-loss medications such as semaglutide and tirzepatide, published to help you compare services. It is not medical advice, it does not create a doctor-patient relationship, and it is not a substitute for a consultation with a licensed clinician who knows your history. Treatments Hub is not a medical provider, pharmacy or clinic and does not prescribe, sell or dispense medication. Do not start, stop or change any treatment because of something you read here, and do not delay seeking care; in an emergency call 911.

Semaglutide and tirzepatide carry an FDA boxed warning about thyroid C-cell tumours seen in rodents and are not for anyone with a personal or family history of medullary thyroid carcinoma or MEN 2, nor for use in pregnancy. Compounded versions sold by telehealth providers are prepared by state-licensed pharmacies and are not FDA-approved products. Where a review or post on this page mentions weight lost, that is one person's result and is not typical; results vary widely.

Medical and scientific statements on this site are checked against the sources linked on the page by our medical content reviewer, who does not choose providers or set prices. Prices, plans and customer reviews are each provider's published figures and customers' own words on the dates stated. We may earn a commission from provider links. The full medical and advertising disclaimer explains all of this in detail.

Sources & medical references

Treatment facts on this page are grounded in regulatory guidance and peer-reviewed research. Pricing and plan details come from each provider's published information. This content is for information only and is not medical advice - always consult a licensed clinician before starting treatment.

  1. 1.Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1 trial) - New England Journal of Medicine, 2021
  2. 2.Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1 trial) - New England Journal of Medicine, 2022
  3. 3.FDA Approves New Drug Treatment for Chronic Weight Management (semaglutide / Wegovy) - U.S. Food & Drug Administration, 2021
  4. 4.FDA Approves New Medication for Chronic Weight Management (tirzepatide / Zepbound) - U.S. Food & Drug Administration, 2023
  5. 5.FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss - U.S. Food & Drug Administration
  6. 6.Human Drug Compounding (503A pharmacy standards) - U.S. Food & Drug Administration
  7. 7.Semaglutide Injection - drug information - MedlinePlus, U.S. National Library of Medicine (NIH)